Partner Headlines - INFI

  1. Infinity Reports Topline Data From Phase 2a Exploratory Study ...

    Benzinga
  2. 3 Partnerships Pushing The Pharmaceutical Sector Forward

    Benzinga
  3. Pharmacyclics Price Target Cut On Higher Spending

    IBD
  4. Benzinga's Top Upgrades

    Benzinga
  5. JMP Securities Upgrades Infinity Pharmaceuticals To Market Outperform

    Benzinga
  6. Infinity, AbbVie team on drug

    IBD
  7. S&P 500 Struggles To Hold 2,000 As Commodities Rebound

    Benzinga
  8. Midday Gainers From Wednesday, September 3

    Benzinga
  9. Infinity Pharma Joins AbbVie On Blood Cancer Drug

    IBD
  10. NASDAQ Tumbles 0.5%; Infinity Pharmaceuticals Jumps On Deal With ...

    Benzinga
  11. Markets Gain; Toll Brothers Profit Beats Estimates

    Benzinga
  12. Benzinga's Volume Movers

    Benzinga
  13. Morning Market Movers

    Benzinga
  14. Stock Futures Up And Climbing; Baidu Heads China Stock Rally

    IBD
  15. Benzinga's Top #PreMarket Gainers

    Benzinga
  16. What You Need to Know About the Roche-InterMune Deal

    Benzinga
  17. Markets Open Higher; Burger King In Talks To Buy Tim Hortons

    Benzinga
  18. InterMune's Roche Deal Sends Peer Group Up

    Benzinga
  19. 3 Small-Cap Biotechs That Institutions Are Loving

    Benzinga
  20. UPDATE: Morgan Stanley Initiates Coverage On Infinity Pharmaceuticals ...

    Benzinga
  21. The Top Five Drug Launches Of 2013

    IBD
  22. UPDATE: Credit Suisse Downgrades Infinity Pharmaceuticals on ...

    Benzinga
  23. Benzinga's Top Downgrades

    Benzinga
  24. Celgene's stock hits new high

    IBD
  25. Mid-Day Market Update: Sysco Shares Rise Following Merger with ...

    Benzinga
  26. Celgene, Infinity Rise On Blood Cancer Drug Data

    IBD
  27. Benzinga's Volume Movers

    Benzinga
  28. Infinity Reports Encouraging Phase 1 IPI-145 Data at ASH

    Benzinga
  29. Infinity Announces Updated Phase 1 Data of IPI-145 in iNLH at ...

    Benzinga
  30. Infinity Announces Updated Phase 1 Data of IPI-145 in iNLH at ...

    Benzinga
  31. UPDATE: William Blair Initiates Coverage on Infinity Pharmaceuticals ...

    Benzinga
  32. Benzinga's Top Initiations

    Benzinga
  33. The Best Small Cap Performers of 2012

    Benzinga
  34. Stocks Hitting 52-Week Highs

    Benzinga
  35. Infinity Pharma Amends Millennium Deal for PI3K-Delta, Gamma

    Benzinga
  36. Infinity Announces Amended PI3K-Delta,Gamma Agreement with Millennium

    Benzinga
  37. Infinity Announces Closing of Public Offering and Exercise of ...

    Benzinga
  38. Stocks Hitting 52-Week Highs

    Benzinga
  39. Infinity Pharma Prices 5.696M Shares at $26.33

    Benzinga
  40. Mid-Afternoon Market Update: Markets Continue to Rise, Diamond ...

    Benzinga
  41. Infinity Pharma Shares Rebound Over $22 Following Phase I Data ...

    Benzinga
  42. UPDATE: Jefferies Downgrades Infinity Pharmaceuticals to Hold ...

    Benzinga
  43. INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q)

    GuruFocus
  44. Stocks Hitting 52-Week Highs

    Benzinga
  45. UPDATE: Stifel Nicolaus Initiates Infinity Pharmaceuticals at ...

    Benzinga
  46. INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q)

    GuruFocus
  47. Health Care Sector Wrap

    FoxBusiness
  48. Synacor, American Capital Mortgage Investment Crp, Other Stocks ...

    FoxBusiness
  49. Infinity Pharmaceuticals Shuts Down Cancer Trials

    Benzinga
  50. Morning Market Losers

    Benzinga
  51. Benzinga's Top Pre-Market Losers

    Benzinga
  52. A Peek Into The Market Before The Trading Starts

    Benzinga
  53. UPDATE: Piper Jaffray Lowers PT on Infinity Pharmaceuticals to ...

    Benzinga
  54. Infinity Plummets on Disappointing Phase 2 Study

    Benzinga
  55. Piper Jaffray Lowers PT on Infinity Pharmaceuticals to $8

    Benzinga
  56. Infinity Reports Update from Phase 2 Study of Saridegib Plus ...

    Benzinga
  57. Infinity Reports New Data from Phase 1b Trial of Saridegib in ...

    Benzinga
Trading Center